Search research articles
Contact Us
Filters
Showing results (111-120 of 121) with videos related to
Page
of 13
Sort By:
Klinische Wochenschrift
|
June 15, 1982
A randomized study of combination chemotherapy (VAC-FMC) with or without immunostimulation by Corynebacterium parvum in metastatic breast cancer
D Fritze, R Becher, B Massner, et al.
Leukemia
|
April 15, 2005
Gender aspects in chronic myeloid leukemia: long-term results from randomized studies
U Berger, O Maywald, M Pfirrmann, et al.
Leukemia
|
April 1, 1997
Randomized studies with interferon in chronic myelogenous leukemia (CML) and comparative molecular aspects. German CML Study Group
R Hehlmann, A Willer, H Heimpel, et al.
Onkologie
|
June 4, 2005
Adjuvant therapy with edrecolomab versus observation in stage II colon cancer: a multicenter randomized phase III study
G Hartung, R-D Hofheinz, Y Dencausse, et al.
Medizinische Klinik (Munich, Germany : 1983)
|
April 12, 1996
[Intensive post-remission therapy in acute myeloid leukemia. Results of a prospective comparative study by the South Germany Hemoblastosis Group]
G Hübner, H Link, P Schönrock-Nabulsi, et al.
Leukemia
|
September 13, 2003
Chronic myeloid leukemia in the elderly: long-term results from randomized trials with interferon alpha
U Berger, G Engelich, O Maywald, et al.
European Journal of Cancer
|
January 1, 1980
Adjuvant chemotherapy with chlorambucil and 5-fluorouracil in primary breast cancer (Cooperative Study Heidelberg)
M Kaufmann, D V Fournier, H Sievers, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
January 1, 1981
Comparison of ftorafur with 5-fluorouracil in combination chemotherapy of advanced gastrointestinal carcinoma
W Queisser, G Schnitzler, J Schaefer, et al.
Blood
|
November 26, 1999
Interferon-alpha before allogeneic bone marrow transplantation in chronic myelogenous leukemia does not affect outcome adversely, provided it is discontinued at least 90 days before the procedure
R Hehlmann, A Hochhaus, H J Kolb, et al.
Bone Marrow Transplantation
|
May 1, 1996
Randomized study of the combination of hydroxyurea and interferon alpha versus hydroxyurea monotherapy during the chronic phase of chronic myelogenous leukemia (CML Study II). The German CML Study Group
R Hehlmann, H Heimpel, D K Hossfeld, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 121) with videos related to
Sort By:
Page
of 13
Klinische Wochenschrift
|
June 15, 1982
A randomized study of combination chemotherapy (VAC-FMC) with or without immunostimulation by Corynebacterium parvum in metastatic breast cancer
D Fritze, R Becher, B Massner, et al.
Leukemia
|
April 15, 2005
Gender aspects in chronic myeloid leukemia: long-term results from randomized studies
U Berger, O Maywald, M Pfirrmann, et al.
Leukemia
|
April 1, 1997
Randomized studies with interferon in chronic myelogenous leukemia (CML) and comparative molecular aspects. German CML Study Group
R Hehlmann, A Willer, H Heimpel, et al.
Onkologie
|
June 4, 2005
Adjuvant therapy with edrecolomab versus observation in stage II colon cancer: a multicenter randomized phase III study
G Hartung, R-D Hofheinz, Y Dencausse, et al.
Medizinische Klinik (Munich, Germany : 1983)
|
April 12, 1996
[Intensive post-remission therapy in acute myeloid leukemia. Results of a prospective comparative study by the South Germany Hemoblastosis Group]
G Hübner, H Link, P Schönrock-Nabulsi, et al.
Leukemia
|
September 13, 2003
Chronic myeloid leukemia in the elderly: long-term results from randomized trials with interferon alpha
U Berger, G Engelich, O Maywald, et al.
European Journal of Cancer
|
January 1, 1980
Adjuvant chemotherapy with chlorambucil and 5-fluorouracil in primary breast cancer (Cooperative Study Heidelberg)
M Kaufmann, D V Fournier, H Sievers, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
January 1, 1981
Comparison of ftorafur with 5-fluorouracil in combination chemotherapy of advanced gastrointestinal carcinoma
W Queisser, G Schnitzler, J Schaefer, et al.
Blood
|
November 26, 1999
Interferon-alpha before allogeneic bone marrow transplantation in chronic myelogenous leukemia does not affect outcome adversely, provided it is discontinued at least 90 days before the procedure
R Hehlmann, A Hochhaus, H J Kolb, et al.
Bone Marrow Transplantation
|
May 1, 1996
Randomized study of the combination of hydroxyurea and interferon alpha versus hydroxyurea monotherapy during the chronic phase of chronic myelogenous leukemia (CML Study II). The German CML Study Group
R Hehlmann, H Heimpel, D K Hossfeld, et al.
Page
of 13